Next Article in Journal
Vitamin D Deficiency and Oral Health: A Comprehensive Review
Previous Article in Journal
Effect of Supplementation with Saccharomyces Boulardii on Academic Examination Performance and Related Stress in Healthy Medical Students: A Randomized, Double-Blind, Placebo-Controlled Trial
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Metabolites, Nutrients, and Lifestyle Factors in Relation to Coffee Consumption: An Environment-Wide Association Study

by
Mohamed A. Elhadad
1,2,
Nena Karavasiloglou
3,
Wahyu Wulaningsih
4,
Konstantinos K Tsilidis
5,6,
Ioanna Tzoulaki
5,6,
Chirag J Patel
7 and
Sabine Rohrmann
3,*
1
Institute for Medical Information Processing, Biometry and Epidemiology, Ludwig Maximilian University of Munich, 81377 Munich, Germany
2
Research Unit of Molecular Epidemiology, Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany
3
Division of Chronic Disease Epidemiology; Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, 8091 Zurich, Switzerland
4
MRC Unit for Lifelong Health and Ageing at University College London, London WC1E 6BT, UK
5
Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, 45110 Ioannina, Greece
6
Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London SW7 2BU, UK
7
Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115, USA
*
Author to whom correspondence should be addressed.
Nutrients 2020, 12(5), 1470; https://doi.org/10.3390/nu12051470
Submission received: 26 April 2020 / Revised: 13 May 2020 / Accepted: 15 May 2020 / Published: 19 May 2020
(This article belongs to the Section Nutritional Epidemiology)

Abstract

:
Coffee consumption has been inversely associated with various diseases; however, the underlying mechanisms are not entirely clear. We used data of 17,752 Third National Health and Nutrition Examination Survey participants to investigate the association of 245 metabolites, nutrients, and lifestyle factors with coffee consumption. We used data from the first phase (n = 8825) to identify factors with a false discovery rate of <5%. We then replicated our results using data from the second phase (n = 8927). Regular coffee consumption was positively associated with active and passive smoking, serum lead and urinary cadmium concentrations, dietary intake of potassium and magnesium, and aspirin intake. In contrast, regular coffee consumption was inversely associated with serum folate and red blood cell folate levels, serum vitamin E and C, and beta-cryptoxanthin concentrations, Healthy Eating Index score, and total serum bilirubin. Most of the aforementioned associations were also observed for caffeinated beverage intake. In our assessment of the association between coffee consumption and selected metabolites, nutrients, and lifestyle factors, we observed that regular coffee and caffeinated beverage consumption was strongly associated with smoking, serum lead levels, and poorer dietary habits.

1. Introduction

Coffee is the most widely consumed beverage worldwide [1,2], and coffee and caffeinated beverages are some of the most studied beverages nowadays. Since its discovery, drinking coffee has been a growing trend around the globe. Such popularity has cultivated questions on the health effects of its consumption. However, findings in the literature are contradicting. On one hand, coffee has been associated with lower mortality risk [3,4,5,6] regardless of the drinkers’ genetically determined caffeine metabolism capacity [7]. Additionally, coffee has been associated with decreased risk of dementia and Alzheimer’s disease [8,9], Parkinson’s disease [10], type 2 diabetes [11,12], cardiovascular disease (CVD) [13] and certain cancers such as colorectal [6,14], endometrial [6,15], prostate [6,16], and liver cancer [17]. In contrast, studies have reported positive associations between coffee consumption and the risk of some cancers, namely gastric [18,19] and laryngeal cancers [20]. Null associations have been reported for esophageal [21,22] and ovarian [23,24,25] cancers and coffee consumption. Coffee consumption has also been associated with increased risk of pregnancy complications [26,27] and some CVD risk factors (e.g., higher blood cholesterol levels and blood pressure [28,29,30]). While some studies have suggested a positive association [31] between coffee consumption and CVD risk, meta-analysis studies showed that there is no risk and even demonstrated benefit of moderate coffee consumption against CVD, all-cause mortality, and some cancers [32,33,34]. Furthermore, Mendelian randomization studies have shown no causal effect of coffee consumption on CVD or all-cause mortality; U-shaped associations were reported in observational studies [35,36].
Such heterogeneity in reported effects could be due to the underlying differences between studies. The definition of coffee consumption is hard to harmonize, particularly due to the wide variety of coffee types, preparation techniques, and consumption habits. For example, boiled coffee contains cafestol and kahweol, which were implicated in the cholesterol-raising effect of coffee, and these compounds could be removed by using brewed or filtered coffee [1].
Metabolites of caffeine and other chemical components of coffee have received much attention because they might play a role in mechanisms of health effects and could be used as biomarkers of coffee consumption. Their association with disease biomarkers is particularly interesting, as they could help identify mediators between coffee consumption and positive health effects. For example, coffee consumption was found to be inversely associated with hepatic inflammation markers [37] and hepatocellular carcinoma [38], as well as increased insulin response [39]. The mechanism behind the relationship between coffee and liver cancer is still unclear, but the inverse association with liver damage markers and the positive association with antioxidants in the coffee might be part of the answer [40,41].
Our study used an environment-wide association study (EWAS) technique to identify the metabolites, nutrients, and lifestyle factors that are associated with coffee or caffeinated beverage consumption.

2. Materials and Methods

2.1. Study Population

We used data from the Third National Health and Nutrition Examination Survey (NHANES III) to investigate the association between coffee consumption and metabolites, nutrients, and lifestyle factors. NHANES III was a cross-sectional US survey that consisted of two phases (1988–1991 and 1991–1994). The survey used representative multistage stratified, clustered probability sampling of the US population. NHANES III data are publicly available and can be accessed online (https://wwwn.cdc.gov). Thus, institutional review board approval and oversight were not required for our study.
Based on the survey design, both phases of the NHANES III can be used independently. In our study, the first phase was used as a discovery set and the second as a replication set. Of all NHANES III participants, only data of participants at least eighteen years old at enrollment were used in the present study (n = 19,618). Furthermore, participants with zero weights were excluded from our analyses leading to our final study population of 17,752 participants (nPhase 1 = 8825, nPhase 2 = 8927).

2.2. Assessment of Coffee and Caffeinated Beverage Consumption

Habitual consumption of coffee, tea, and soda (including cola) was assessed using a food frequency questionnaire (FFQ) that assessed the frequency (in times per month) but not the exact amount of food consumed. The questionnaire included questions regarding consumption of caffeinated and non-caffeinated coffee, tea, and soda. However, since consumption of non-caffeinated coffee, tea and soda was very infrequent, we focused only on the consumption of caffeinated beverages, which we call "regular" in the rest of the manuscript. Total caffeinated beverage consumption expressed as number of cups per day (by assuming that the frequency reported corresponded to cups of coffee consumed during the month), was calculated by summing the consumption of regular coffee, regular tea, regular sodas (including colas), and diet sodas (including diet colas).

2.3. Assessment of the Metabolites, Nutrients, and Lifestyle Factors

In our analysis, we included 245 metabolites, nutrients, and lifestyle factors (29 factors on body measurements, disease history, and medication use; 32 lifestyle factors; 80 metabolites and 104 dietary nutrients), which have previously been assessed and are publicly available (https://wwwn.cdc.gov). NHANES III participants were interviewed and underwent physical examinations in a mobile examination center. Information on some factors was obtained during the interview, while others were obtained via laboratory testing. Dietary information was collected with 24-hour dietary recall interviews, using an automated data collection instrument [42]. All NHANES III participants were asked to complete a 24-h dietary recall during their visit at the Medical Examination Center (MEC). In addition, about 5% of all adult examinees received a second replicate MEC examination that included a 24-h dietary recall; this replicate data was used to estimate within- and between-person variances for estimating nutrient intake distributions. Data collection was scheduled as such as to include all days of the week and throughout the year. Apart from reproductive factors, all factors were investigated in both men and women (Supplementary Table S1). Continuous factors were Z-score standardized.

2.4. Statistical Analysis

2.4.1. Discovery Phase

Using Phase 1 of the NHANES III, we assessed the association of metabolites, nutrients, and lifestyle factors with regular coffee consumption. Survey weighted linear regression models were used to examine the association of regular coffee consumption (continuous, cups per month), with continuous and dichotomous metabolites, nutrients, and lifestyle factors as explanatory variables. We then corrected for multiple testing using false discovery rate (FDR). We estimated FDR using the Benjamini–Hochberg step down method; factors at FDR < 0.05 were considered significant. The following factors were a priori considered confounders rather than predictors in this study: age, sex, race/ethnicity, education, and socioeconomic status (SES). Race/ethnicity was categorized into four groups: Non-Hispanic white, Non-Hispanic black, Mexican–American, and Other. Education was categorized as less than high school, high school equivalent, and higher than high school. SES was estimated using poverty-to-income ratio (PIR), a ratio of total family income to the official poverty threshold according to the family size. A PIR < 1 indicates that income is below the poverty threshold. We categorized PIR into four categories (PIR < 1, 1 ≤ PIR < 2, 2 ≤ PIR < 3, and PIR ≥ 3).

2.4.2. Replication Phase

To replicate the results of the discovery phase we used data from Phase 2 of NHANES III. For the replication, we considered only the statistically significant factors of the discovery set (FDR < 0.05). Factors were considered relevant if their association with coffee consumption reported a p ≤ 0.05 in the replication set. Additionally, we examined the associations between these replicated metabolites, nutrients, and lifestyle factors and the consumption of total caffeinated beverages (continuous, cups per month).
Since the food group “soft drinks” includes not only caffeinated beverages, but also non-caffeinated soft drinks, we checked their association with the replicated metabolites, nutrients, and lifestyle factors for regular coffee consumption. We defined soft drinks as the sum of regular sodas and diet sodas and included it as a continuous variable in our model.
In sensitivity analyses, we investigated whether the replicated metabolites, nutrients, and lifestyle factors for regular coffee consumption were similarly associated in men and women. We used survey weighted logistic regression to assess the sex-specific associations between dichotomized regular coffee consumption (at least one cup per day vs. less) and the metabolites, nutrients, and lifestyle factors replicated in the total study population. We tested for interactions with sex by adding an interaction term in all the weighted logistic regression models between coffee consumption and the metabolites, nutrients, and lifestyle factors replicated in the total study population.
Datasets were prepared for analysis using the Statistical Analysis Software (SAS) university edition (SAS Institute, Cary, NC, US) and analyses were performed using R (version 3.2.1). Analyses were performed using the survey package including sampling weights to account for the complex survey design and survey non-response.

3. Results

Among 8292 male study participants, 4111 consumed one cup of coffee or more per day (mean consumption 72.4 cups per month), and 4766 out of 9460 female participants consumed coffee at least once per day (mean consumption 62.0 cups per month; Table 1). The mean age of daily coffee drinkers was 46.6 years for men and 48.6 years for women; non-daily drinkers were younger than daily drinkers. Mean body mass index (BMI) was 26.6 kg/m2 for men and 26.3 kg/m2 for women, which was similar between daily and non-daily coffee drinkers. Daily coffee consumption was more common in Non-Hispanic whites than in Non-Hispanic blacks and in participants with higher SES as indicated by the PIR. Distribution of studied metabolites, nutrients, and lifestyle factors in men and women are provided as supplementary material (Supplementary Table S1).

3.1. Discovery Phase

We performed a systematic screening of associations between the metabolites, nutrients, and lifestyle factors with regular coffee and total caffeinated beverage consumption. Out of the 245 metabolites, nutrients, and lifestyle factors initially investigated, 32 factors were identified in the discovery set with FDR < 0.05 (Figure 1; Supplementary Table S2).

3.2. Replication Phase

Table 2 shows the 30 factors replicated that were significantly associated with regular coffee consumption. To summarize, coffee consumption was positively associated with both active and passive smoking, serum lead and urinary cadmium concentrations, aspirin use during the last month, and intake of magnesium, potassium, and water. It was inversely associated with folate levels in serum and red blood cells, serum concentrations of vitamin E and C and beta-cryptoxanthin, serum total bilirubin, Healthy Eating Index, and fruit intake (as assessed by the Healthy Eating Index). Most of these factors were also associated with intake of total caffeinated beverages, although not all replicated factors were statistically significant (Table 3). The association between soft drinks intake and factors replicated for regular coffee consumption were of the same direction as for regular coffee consumption (i.e., inverse association for vitamin serum levels and the Healthy Eating Index; positive association for passive smoking), but we did not see statistically significant associations with factors related to active smoking, besides former smoking.
In sex-specific analyses, all p-values for interactions were <0.05. However, the association between the replicated factors for regular coffee consumption identified in the replication phase and daily coffee consumption was similar in men and in women (Supplementary Table S3), with most replicated factors for regular coffee consumption showing up as statistically significant.

4. Discussion

In our systematic, cross-sectional analysis of 245 metabolites, nutrients, and lifestyle factors, using a representative sample of the US population, regular coffee consumption was positively associated with smoking (both active and passive), and serum lead and urinary cadmium concentrations. In contrast, regular coffee consumption was inversely associated with serum folate, red blood cell folate levels, and the Healthy Eating Index score.
The significant association between regular coffee consumption and smoking (active and passive) could be explained by the stimulation of caffeine metabolism by smoking and thereby the higher tolerance of caffeine in smokers (i.e., they may drink more coffee or caffeine-containing beverages than non-smokers) [43,44,45]. According to a recent Mendelian randomization study, the amount of coffee consumed is unlikely to significantly affect the amount of cigarette smoking [46]. The association between coffee consumption and smoking could also be attributed to personal liability to have addictive habits [47], or a combination of all the aforementioned mechanisms. However, in this project, we are unable to judge the direction of the association between coffee consumption and smoking.
The positive association between regular coffee consumption and serum lead or urinary cadmium concentrations in our study potentially reflects coffee contamination with heavy metals [48]. The inverse association between regular coffee consumption and serum folate or red blood cell folate concentration might indicate that coffee drinkers follow a diet less rich in fruits and vegetables compared to non-regular coffee drinkers. An inverse association between coffee consumption and folate concentration was also reported in a Norwegian study [49]. Alternately, this inverse association might be attributed to altered nutrient metabolism due to coffee consumption.
Most factors associated with regular coffee consumption were also associated with total intake of caffeinated beverages, with the exception of fructose, glucose, magnesium, and potassium (as assessed from the 24-h dietary recall). As expected, fructose and glucose intake were positively associated with the consumption of soft drinks. Soft drinks were also inversely associated with circulating levels of folate, vitamin C and vitamin E, but not with smoking, indicating that soft drinks per se do not drive the association between the replicated factors for regular coffee consumption and the total caffeinated beverage consumption. A genome-wide association study, reporting no association between the genetic risk for coffee consumption and soft drink consumption, supports this finding [50].
Associations between coffee consumption and favorable metabolic profile (i.e., oxidative stress [40,51], hepatic function [37,52], or metabolic syndrome [53,54] markers) have been reported in the literature. These associations potentially explain the protective effect of coffee consumption on various diseases, including type 2 diabetes [11,12], different cancers [5,6,14,15,16,17,38] and mortality [5,6]. We acknowledge that our analysis did not detect similar significant associations. This could reflect the diversity in coffee composition (differences by type of coffee, preparation of coffee etc.) and the need for better-powered studies that are able to detect significant associations of smaller effect size.
To our knowledge, this is the first study that systematically looked at the cross-sectional association between coffee consumption and various metabolites, nutrients, and lifestyle factors simultaneously. Such associations have been the center of interest in clinical research but with reporting of only a limited group of metabolites, nutrients, or lifestyle factors in most studies. With our approach, we intended to find associations between coffee consumption and markers/indicators that represent coffee metabolites without having a specific disease in mind, thus, avoiding selective reporting and false positive results. Identifying coffee metabolites and using them as surrogates of coffee consumption or as surrogates of a certain component in coffee can help avoid misclassification bias. Our systematic approach to test associations of multiple factors with coffee or caffeinated beverage consumption allowed us to avoid selective testing of certain factors, which could be a source of bias and false positive results. Additionally, the detailed information collection at baseline allowed us to adjust for major confounders and we further replicated our results in a different dataset to verify the strong statistical associations of the results reported.
Using NHANES III as a representative sample of the US population allowed for generalizability of our results; however, since this is a cross-sectional study, causality cannot be assessed. Some of the tested factors were self-reported, and dietary intake was mainly assessed using an FFQ that asked for frequency of consumption but not portion size. This could have resulted in misclassification not only in coffee and other beverage intake but also in confounding variables. Additionally, no information was available on the caffeine content of soft drinks. Finally, the wide variety of coffee types, cup sizes, and preparation techniques makes it challenging to accurately classify coffee consumption into subgroups or to accurately estimate caffeine intake.
Acknowledging these limitations, we showed a systematic approach for testing the metabolites, nutrients, and lifestyle factors associated with coffee and related beverage consumption. These associations could pave the way for future studying of the benefits and risks of these beverages and their relations to diseases and mortality.

Supplementary Materials

The following are available online at https://www.mdpi.com/2072-6643/12/5/1470/s1: Table S1. Survey weighted descriptive statistics of metabolites, nutrients, and lifestyle factors in the Third National Health and Nutrition Examination Survey (NHANES III). Survey weighted means and standard errors (SE) are reported for continuous variables while proportions are reported for categorical variables; Table S2. Associations between metabolites, nutrients, and lifestyle factors and regular coffee consumption in the discovery set. All models were adjusted for age, race/ethnicity, education, and poverty-to-income ratio (PIR). Benjamini–Hochberg adjusted p-values for false discovery rate (FDR) < 5% are shown; Table S3. Validated metabolites, nutrients, and lifestyle factors of regular coffee consumption and their association with coffee consumption (continuous) stratified by sex.

Author Contributions

Conceptualization, M.A.E. and S.R.; methodology and software, W.W., K.K.T., I.T., and C.J.P.; formal analysis, M.A.E. and N.K.; writing—original draft preparation, M.A.E.; writing—review and editing, M.A.E. and N.K.; visualization, M.A.E. and N.K.; supervision, S.R. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Gonzalez de Mejia, E.; Ramirez-Mares, M.V. Impact of caffeine and coffee on our health. Trends Endocrinol. Metab. 2014, 25, 489–492. [Google Scholar] [CrossRef] [PubMed]
  2. Butt, M.S.; Sultan, M.T. Coffee and its consumption: Benefits and risks. Crit. Rev. Food. Sci. Nutr. 2011, 51, 363–373. [Google Scholar] [CrossRef] [PubMed]
  3. Gunter, M.J.; Murphy, N.; Cross, A.J.; Dossus, L.; Dartois, L.; Fagherazzi, G.; Kaaks, R.; Kuhn, T.; Boeing, H.; Aleksandrova, K.; et al. Coffee Drinking and Mortality in 10 European Countries: A Multinational Cohort Study. Ann. Intern. Med. 2017, 167, 236–247. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Kim, Y.; Je, Y.; Giovannucci, E. Coffee consumption and all-cause and cause-specific mortality: A meta-analysis by potential modifiers. Eur. J. Epidemiol. 2019, 34, 731–752. [Google Scholar] [CrossRef] [PubMed]
  5. Poole, R.; Kennedy, O.J.; Roderick, P.; Fallowfield, J.A.; Hayes, P.C.; Parkes, J. Coffee consumption and health: Umbrella review of meta-analyses of multiple health outcomes. BMJ 2017, 359. [Google Scholar] [CrossRef] [Green Version]
  6. Grosso, G.; Godos, J.; Galvano, F.; Giovannucci, E.L. Coffee, Caffeine, and Health Outcomes: An Umbrella Review. Annu. Rev. Nutr. 2017, 37, 131–156. [Google Scholar] [CrossRef] [Green Version]
  7. Loftfield, E.; Cornelis, M.C.; Caporaso, N.; Yu, K.; Sinha, R.; Freedman, N. Association of Coffee Drinking With Mortality by Genetic Variation in Caffeine Metabolism: Findings From the UK Biobank. Jama Intern. Med. 2018, 178, 1086–1097. [Google Scholar] [CrossRef] [Green Version]
  8. Xu, W.; Tan, L.; Wang, H.F.; Jiang, T.; Tan, M.S.; Tan, L.; Zhao, Q.F.; Li, J.Q.; Wang, J.; Yu, J.T. Meta-analysis of modifiable risk factors for Alzheimer’s disease. J. Neurol. Neurosurg. Psychiatry 2015, 86, 1299–1306. [Google Scholar] [CrossRef]
  9. Carman, A.J.; Dacks, P.A.; Lane, R.F.; Shineman, D.W.; Fillit, H.M. Current evidence for the use of coffee and caffeine to prevent age-related cognitive decline and Alzheimer’s disease. J. Nutr. Health Aging 2014, 18, 383–392. [Google Scholar] [CrossRef]
  10. Qi, H.; Li, S. Dose-response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson’s disease. Geriatr. Gerontol. Int. 2014, 14, 430–439. [Google Scholar] [CrossRef]
  11. Ding, M.; Bhupathiraju, S.N.; Chen, M.; van Dam, R.M.; Hu, F.B. Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: A systematic review and a dose-response meta-analysis. Diabetes Care 2014, 37, 569–586. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Huxley, R.; Lee, C.M.; Barzi, F.; Timmermeister, L.; Czernichow, S.; Perkovic, V.; Grobbee, D.E.; Batty, D.; Woodward, M. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: A systematic review with meta-analysis. Arch. Intern. Med. 2009, 169, 2053–2063. [Google Scholar] [CrossRef] [PubMed]
  13. Ding, M.; Bhupathiraju, S.N.; Satija, A.; van Dam, R.M.; Hu, F.B. Long-term coffee consumption and risk of cardiovascular disease: A systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation 2014, 129, 643–659. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Tian, C.; Wang, W.; Hong, Z.; Zhang, X. Coffee consumption and risk of colorectal cancer: A dose-response analysis of observational studies. Cancer Causes Control 2013, 24, 1265–1268. [Google Scholar] [CrossRef] [PubMed]
  15. Zhou, Q.; Luo, M.L.; Li, H.; Li, M.; Zhou, J.G. Coffee consumption and risk of endometrial cancer: A dose-response meta-analysis of prospective cohort studies. Sci. Rep. 2015, 5, 13410. [Google Scholar] [CrossRef]
  16. Liu, H.; Hu, G.H.; Wang, X.C.; Huang, T.B.; Xu, L.; Lai, P.; Guo, Z.F.; Xu, Y.F. Coffee consumption and prostate cancer risk: A meta-analysis of cohort studies. Nutr. Cancer 2015, 67, 392–400. [Google Scholar] [CrossRef]
  17. Sang, L.X.; Chang, B.; Li, X.H.; Jiang, M. Consumption of coffee associated with reduced risk of liver cancer: A meta-analysis. BMC Gastroenterol. 2013, 13, 34. [Google Scholar] [CrossRef] [Green Version]
  18. Zeng, S.B.; Weng, H.; Zhou, M.; Duan, X.L.; Shen, X.F.; Zeng, X.T. Long-Term Coffee Consumption and Risk of Gastric Cancer: A PRISMA-Compliant Dose-Response Meta-Analysis of Prospective Cohort Studies. Medicine 2015, 94, e1640. [Google Scholar] [CrossRef]
  19. Shen, Z.; Liu, H.; Cao, H. Coffee consumption and risk of gastric cancer: An updated meta-analysis. Clin. Res. Hepatol. Gastroenterol. 2015, 39, 245–253. [Google Scholar] [CrossRef]
  20. Chen, J.; Long, S. Tea and coffee consumption and risk of laryngeal cancer: A systematic review meta-analysis. PLoS ONE 2014, 9, e112006. [Google Scholar] [CrossRef]
  21. Zamora-Ros, R.; Lujan-Barroso, L.; Bueno-de-Mesquita, H.B.; Dik, V.K.; Boeing, H.; Steffen, A.; Tjonneland, A.; Olsen, A.; Bech, B.H.; Overvad, K.; et al. Tea and coffee consumption and risk of esophageal cancer: The European prospective investigation into cancer and nutrition study. Int. J. Cancer 2014, 135, 1470–1479. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Zhang, J.; Zhou, B.; Hao, C. Coffee consumption and risk of esophageal cancer incidence: A meta-analysis of epidemiologic studies. Medicine 2018, 97, e0514. [Google Scholar] [CrossRef] [PubMed]
  23. Salari-Moghaddam, A.; Milajerdi, A.; Surkan, P.J.; Larijani, B.; Esmaillzadeh, A. Caffeine, type of coffee and risk of ovarian cancer: A dose-response meta-analysis of prospective studies. J. Clin. Endocrinol. Metab. 2019. [Google Scholar] [CrossRef] [PubMed]
  24. Shafiei, F.; Salari-Moghaddam, A.; Milajerdi, A.; Larijani, B.; Esmaillzadeh, A. Coffee and caffeine intake and risk of ovarian cancer: A systematic review and meta-analysis. Int. J. Gynecol. Cancer 2019, 29, 579–584. [Google Scholar] [CrossRef] [PubMed]
  25. Berretta, M.; Micek, A.; Lafranconi, A.; Rossetti, S.; Di Francia, R.; De Paoli, P.; Rossi, P.; Facchini, G. Coffee consumption is not associated with ovarian cancer risk: A dose-response meta-analysis of prospective cohort studies. Oncotarget 2018, 9, 20807–20815. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Rhee, J.; Kim, R.; Kim, Y.; Tam, M.; Lai, Y.; Keum, N.; Oldenburg, C.E. Maternal Caffeine Consumption during Pregnancy and Risk of Low Birth Weight: A Dose-Response Meta-Analysis of Observational Studies. PLoS ONE 2015, 10, e0132334. [Google Scholar] [CrossRef] [PubMed]
  27. Okubo, H.; Miyake, Y.; Tanaka, K.; Sasaki, S.; Hirota, Y. Maternal total caffeine intake, mainly from Japanese and Chinese tea, during pregnancy was associated with risk of preterm birth: The Osaka Maternal and Child Health Study. Nutr. Res. 2015, 35, 309–316. [Google Scholar] [CrossRef]
  28. Kokjohn, K.; Graham, M.; McGregor, M. The effect of coffee consumption on serum cholesterol levels. J. Manip. Physiol. Ther. 1993, 16, 327–335. [Google Scholar]
  29. Mesas, A.E.; Leon-Munoz, L.M.; Rodriguez-Artalejo, F.; Lopez-Garcia, E. The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: A systematic review and meta-analysis. Am. J. Clin. Nutr. 2011, 94, 1113–1126. [Google Scholar] [CrossRef]
  30. Higgins, J.P.; Babu, K.M. Caffeine reduces myocardial blood flow during exercise. Am. J. Med. 2013, 126, 730.e1. [Google Scholar] [CrossRef]
  31. Nawrot, T.S.; Perez, L.; Kunzli, N.; Munters, E.; Nemery, B. Public health importance of triggers of myocardial infarction: A comparative risk assessment. Lancet 2011, 377, 732–740. [Google Scholar] [CrossRef]
  32. Wu, J.N.; Ho, S.C.; Zhou, C.; Ling, W.H.; Chen, W.Q.; Wang, C.L.; Chen, Y.M. Coffee consumption and risk of coronary heart diseases: A meta-analysis of 21 prospective cohort studies. Int. J. Cardiol. 2009, 137, 216–225. [Google Scholar] [CrossRef] [PubMed]
  33. Zhao, Y.; Wu, K.; Zheng, J.; Zuo, R.; Li, D. Association of coffee drinking with all-cause mortality: A systematic review and meta-analysis. Public Health Nutr. 2015, 18, 1282–1291. [Google Scholar] [CrossRef] [PubMed]
  34. Yu, X.; Bao, Z.; Zou, J.; Dong, J. Coffee consumption and risk of cancers: A meta-analysis of cohort studies. BMC Cancer 2011, 11, 96. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Cornelis, M.C.; Munafo, M.R. Mendelian Randomization Studies of Coffee and Caffeine Consumption. Nutrients 2018, 10, 1343. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Nordestgaard, A.T.; Nordestgaard, B.G. Coffee intake, cardiovascular disease and all-cause mortality: Observational and Mendelian randomization analyses in 95 000-223 000 individuals. Int. J. Epidemiol. 2016, 45, 1938–1952. [Google Scholar] [CrossRef]
  37. Xiao, Q.; Sinha, R.; Graubard, B.I.; Freedman, N.D. Inverse associations of total and decaffeinated coffee with liver enzyme levels in National Health and Nutrition Examination Survey 1999–2010. Hepatology 2014, 60, 2091–2098. [Google Scholar] [CrossRef] [Green Version]
  38. Aleksandrova, K.; Bamia, C.; Drogan, D.; Lagiou, P.; Trichopoulou, A.; Jenab, M.; Fedirko, V.; Romieu, I.; Bueno-de-Mesquita, H.B.; Pischon, T.; et al. The association of coffee intake with liver cancer risk is mediated by biomarkers of inflammation and hepatocellular injury: Data from the European Prospective Investigation into Cancer and Nutrition. Am. J. Clin. Nutr. 2015, 102, 1498–1508. [Google Scholar] [CrossRef] [Green Version]
  39. Reis, C.E.G.; Dorea, J.G.; da Costa, T.H.M. Effects of coffee consumption on glucose metabolism: A systematic review of clinical trials. J. Tradit. Complement Med. 2019, 9, 184–191. [Google Scholar] [CrossRef]
  40. Chen, J.T.; Kotani, K. Association between coffee consumption and an oxidative stress marker in women. Wien. Klin. Wochenschr. 2015, 127, 567–569. [Google Scholar] [CrossRef]
  41. Agudelo-Ochoa, G.M.; Pulgarin-Zapata, I.C.; Velasquez-Rodriguez, C.M.; Duque-Ramirez, M.; Naranjo-Cano, M.; Quintero-Ortiz, M.M.; Lara-Guzman, O.J.; Munoz-Durango, K. Coffee Consumption Increases the Antioxidant Capacity of Plasma and Has No Effect on the Lipid Profile or Vascular Function in Healthy Adults in a Randomized Controlled Trial. J. Nutr. 2016, 146, 524–531. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Centers for Disease Control and Prevention. Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988–1994; Series 1: Programs and Collection Procedures; Centers for Disease Control and Prevention: Atlanta, GA, USA, 1994; pp. 1–407.
  43. Parsons, W.D.; Neims, A.H. Effect of smoking on caffeine clearance. Clin. Pharmacol. Ther. 1978, 24, 40–45. [Google Scholar] [CrossRef] [PubMed]
  44. Rodenburg, E.M.; Eijgelsheim, M.; Geleijnse, J.M.; Amin, N.; van Duijn, C.M.; Hofman, A.; Uitterlinden, A.G.; Stricker, B.H.; Visser, L.E. CYP1A2 and coffee intake and the modifying effect of sex, age, and smoking. Am. J. Clin. Nutr. 2012, 96, 182–187. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Bjorngaard, J.H.; Nordestgaard, A.T.; Taylor, A.E.; Treur, J.L.; Gabrielsen, M.E.; Munafo, M.R.; Nordestgaard, B.G.; Asvold, B.O.; Romundstad, P.; Davey Smith, G. Heavier smoking increases coffee consumption: Findings from a Mendelian randomization analysis. Int. J. Epidemiol. 2017, 46, 1958–1967. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Ware, J.J.; Tanner, J.A.; Taylor, A.E.; Bin, Z.; Haycock, P.; Bowden, J.; Rogers, P.J.; Davey Smith, G.; Tyndale, R.F.; Munafo, M.R. Does coffee consumption impact on heaviness of smoking? Addiction 2017, 112, 1842–1853. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Juliano, L.M.; Griffiths, R.R. A critical review of caffeine withdrawal: Empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology 2004, 176, 1–29. [Google Scholar] [CrossRef] [PubMed]
  48. Nedzarek, A.; Torz, A.; Karakiewicz, B.; Clark, J.S.; Laszczynska, M.; Kaleta, A.; Adler, G. Concentrations of heavy metals (Mn, Co, Ni, Cr, Ag, Pb) in coffee. Acta Biochim. Pol. 2013, 60, 623–627. [Google Scholar] [CrossRef] [Green Version]
  49. Ulvik, A.; Vollset, S.E.; Hoff, G.; Ueland, P.M. Coffee consumption and circulating B-vitamins in healthy middle-aged men and women. Clin. Chem. 2008, 54, 1489–1496. [Google Scholar] [CrossRef]
  50. Taylor, A.E.; Davey Smith, G.; Munafo, M.R. Associations of coffee genetic risk scores with consumption of coffee, tea and other beverages in the UK Biobank. Addiction 2018, 113, 148–157. [Google Scholar] [CrossRef] [Green Version]
  51. Ishizaka, Y.; Yamakado, M.; Toda, A.; Tani, M.; Ishizaka, N. Relationship between coffee consumption, oxidant status, and antioxidant potential in the Japanese general population. Clin. Chem. Lab. Med. 2013, 51, 1951–1959. [Google Scholar] [CrossRef]
  52. Dickson, J.C.; Liese, A.D.; Lorenzo, C.; Haffner, S.M.; Watkins, S.M.; Hamren, S.J.; Stiles, J.K.; Wagenknecht, L.E.; Hanley, A.J. Associations of coffee consumption with markers of liver injury in the insulin resistance atherosclerosis study. BMC Gastroenterol. 2015, 15, 88. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Mure, K.; Maeda, S.; Mukoubayashi, C.; Mugitani, K.; Iwane, M.; Kinoshita, F.; Mohara, O.; Takeshita, T. Habitual coffee consumption inversely associated with metabolic syndrome-related biomarkers involving adiponectin. Nutrition 2013, 29, 982–987. [Google Scholar] [CrossRef] [PubMed]
  54. Pham, N.M.; Nanri, A.; Yasuda, K.; Kurotani, K.; Kuwahara, K.; Akter, S.; Sato, M.; Hayabuchi, H.; Mizoue, T. Habitual consumption of coffee and green tea in relation to serum adipokines: A cross-sectional study. Eur. J. Nutr. 2015, 54, 205–214. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Manhattan plot depicting the associations between metabolites, nutrients, and lifestyle factors and coffee consumption in the discovery phase. Factors were ordered based on the size of effects (beta coefficient). Variable names are given only for the statistically significant metabolites, nutrients, and lifestyle factors.
Figure 1. Manhattan plot depicting the associations between metabolites, nutrients, and lifestyle factors and coffee consumption in the discovery phase. Factors were ordered based on the size of effects (beta coefficient). Variable names are given only for the statistically significant metabolites, nutrients, and lifestyle factors.
Nutrients 12 01470 g001
Table 1. Baseline characteristics of study participants, the Third National Health and Nutrition Examination Survey (NHANES III).
Table 1. Baseline characteristics of study participants, the Third National Health and Nutrition Examination Survey (NHANES III).
Frequency of Coffee ConsumptionMenWomen
<1 cup/day≥1 cup/day<1 cup/day≥1 cup/day
No. study participants 1 (%)4163 (50.31)4111 (49.69)5182 (54.86)4264 (45.14)
Age, mean (SE), years38.64 (0.49)46.61 (0.51)41.15 (0.53)48.62 (0.56)
BMI, mean (SE), kg/m226.32 (0.14)26.59 (0.13)26.36 (0.24)26.31 (0.13)
Race/Ethnicity, %
Non-Hispanic White69.5281.9971.1680.84
Non-Hispanic Black15.455.7915.487.72
Mexican–American6.275.114.994.44
Other8.767.118.367.00
Education, %
Less than high school9.4513.2510.2712.51
High school equivalent45.8245.7648.9051.99
Higher than high school44.7340.9940.8335.50
PIR category, %
PIR < 112.1810.2417.1612.40
1 ≤ PIR < 221.8318.4722.3622.27
2 ≤ PIR < 321.9821.7620.8119.70
PIR ≥ 344.0149.5339.6745.63
1 Number of study participants is unweighted. Abbreviations: BMI, body mass index; SE, standard error; PIR, poverty-to-income ratio.
Table 2. Replicated metabolites, nutrients, and lifestyle factors associated with regular coffee consumption (assessed as a continuous variable).
Table 2. Replicated metabolites, nutrients, and lifestyle factors associated with regular coffee consumption (assessed as a continuous variable).
FactorNo. 1CoefficientSEp-Value
Water (gm) 2768113.012.421.67 × 10−4
Caffeine (mg) 2768121.572.703.78 × 10−6
Smoked 100+ cigarettes in life (yes, no)813821.582.266.01 × 10−7
Age first smoked cigarettes regularly
(<30, 30–40, 40–50, >50)
80029.681.069.38 × 10−7
Number of cigarettes smoked per day180110.363.257.83 × 10−3
Former smoking (vs. never smoking)621510.491.735.69 × 10−5
Current smoking (vs. never smoking)624834.794.091.97 × 10−6
Smoked at least 20 cigars in life (yes, no)813514.405.161.63 × 10−2
Smoked 20 pipes of tobacco in life (yes, no)813519.346.901.60 × 10−2
Serum cotinine (ng/mL)760312.251.781.68 × 10−5
Does anyone smoke at home? (yes, no)813821.342.349.40 × 10−7
Can smell smoking in office? (yes, no)446715.864.443.86 × 10−3
Number of persons who smoke at home813811.241.661.99 × 10−5
Hours per day can smell smoking at work44678.302.485.79 × 10−3
Took aspirin in last month (yes, no)81275.462.434.47 × 10−2
Serum Lead Concentration (ug/dL)78668.251.714.23 × 10−4
Urinary cadmium (ng/mL)77834.041.522.11 × 10−2
Serum total bilirubin (mg/dL)7771−4.731.293.27 × 10−3
Serum beta cryptoxanthin (ug/dL)7791−4.620.882.16 × 10−4
RBCs folate (ng/mL)7632−6.040.561.70 × 10−7
Serum folate (ng/mL)7824−4.031.278.08 × 10−3
Serum vitamin C (mg/dL)7372−4.210.727.57 × 10−5
Serum vitamin E (ug/dL)7792−3.250.954.94 × 10−3
Fruits, Healthy Eating Index Score 27681−4.061.072.62 × 10−3
Healthy Eating Index Score 27681−5.030.992.82 × 10−4
Energy from carbohydrate (%kcal) 27681−5.171.504.86 × 10−3
Fructose (gm) 27681−5.280.823.22 × 10−5
Glucose (gm) 27681−5.090.992.53 × 10−4
Magnesium (mg) 276814.351.581.75 × 10−2
Potassium (mg) 276815.451.533.89 × 10−3
1 Number of study participants is unweighted. 2 Assessed from 24-hour dietary recall interviews. Abbreviations: gm, gram; mg, milligram; RBCs, red blood cell; SE, standard error.
Table 3. Replicated metabolites, nutrients, and lifestyle factors of regular coffee consumption and their association with consumption of caffeinated beverages and soft drinks (continuous).
Table 3. Replicated metabolites, nutrients, and lifestyle factors of regular coffee consumption and their association with consumption of caffeinated beverages and soft drinks (continuous).
Caffeinated BeveragesSoft Drinks
FactorCoefficientSE p-ValueCoefficientSEp-Value
Water (gm) 119.642.076.32 × 10−73.460.821.20 × 10−3
Caffeine (mg) 1-- 2 --
Smoked 100 + cigarettes in life (yes, no)26.093.011.62 × 10−6--
Age first smoked cigarettes regularly
(<30, 30–40, 40–50, > 50)
11.731.484.19 × 10−6--
Number of cigarettes smoked per day17.222.998.90 × 10−5--
Former smoking (vs. never smoking)11.292.831.78 × 10−35.611.604.27 × 10−3
Current smoking (vs. never smoking)41.764.811.60 × 10−6--
Smoked at least 20 cigars in life (yes, no)19.447.993.16 × 10−2--
Smoked 20 pipes of tobacco in life (yes, no)23.277.621.00 × 10−2--
Serum cotinine (ng/mL)16.012.075.29 × 10−62.630.587.08 × 10−4
Does anyone smoke at home? (yes, no)29.113.251.16 × 10−64.611.273.51 × 10−3
Can smell smoking in office? (yes, no)22.765.932.35 × 10−3--
Number of persons who smoke at home14.862.496.53 × 10−52.400.736.34 × 10−3
Hours per day can smell smoking at work13.272.784.53 × 10−4--
Took aspirin in last month (yes, no)-- --
Serum Lead Concentration (ug/dL)8.091.921.20 × 10−3--
Urinary cadmium (ng/mL)4.991.159.66 × 10−4--
Serum total bilirubin (mg/dL)−6.581.631.61 × 10−3--
Serum beta cryptoxanthin (ug/dL)−9.561.462.82 × 10−5−3.430.543.64 × 10−5
RBCs folate (ng/mL)−9.991.024.55 × 10−7−2.490.662.77 × 10−3
Serum folate (ng/mL)−7.141.351.94 × 10−4−2.390.483.24 × 10−4
Serum vitamin C (mg/dL)−10.371.376.53 × 10−6−4.360.758.85 × 10−5
Serum vitamin E (ug/dL)−3.961.481.99 × 10−2--
Fruits, Healthy Eating Index Score 1−7.861.603.57 × 10−4−2.660.68.31 × 10−4
Healthy Eating Index Score 1−8.871.702.19 × 10−4−2.970.635.13 × 10−4
Energy from carbohydrate (%kcal) 1−4.451.641.90 × 10−2--
Fructose (gm) 1-- 2.740.784.27 × 10−3
Glucose (gm) 1-- 2.760.836.14 × 10−3
Magnesium (mg) 1-- --
Potassium (mg) 1-- --
1 Assessed from 24-h dietary recall interviews. 2 The dashed lines represent coffee-replicated factors that failed replication in either soft drinks or caffeinated beverages consumption. Coefficients are only shown for replicated results. Abbreviations: gm, gram; mg, milligram; RBCs, red blood cell; SE, standard error.

Share and Cite

MDPI and ACS Style

Elhadad, M.A.; Karavasiloglou, N.; Wulaningsih, W.; Tsilidis, K.K.; Tzoulaki, I.; Patel, C.J.; Rohrmann, S. Metabolites, Nutrients, and Lifestyle Factors in Relation to Coffee Consumption: An Environment-Wide Association Study. Nutrients 2020, 12, 1470. https://doi.org/10.3390/nu12051470

AMA Style

Elhadad MA, Karavasiloglou N, Wulaningsih W, Tsilidis KK, Tzoulaki I, Patel CJ, Rohrmann S. Metabolites, Nutrients, and Lifestyle Factors in Relation to Coffee Consumption: An Environment-Wide Association Study. Nutrients. 2020; 12(5):1470. https://doi.org/10.3390/nu12051470

Chicago/Turabian Style

Elhadad, Mohamed A., Nena Karavasiloglou, Wahyu Wulaningsih, Konstantinos K Tsilidis, Ioanna Tzoulaki, Chirag J Patel, and Sabine Rohrmann. 2020. "Metabolites, Nutrients, and Lifestyle Factors in Relation to Coffee Consumption: An Environment-Wide Association Study" Nutrients 12, no. 5: 1470. https://doi.org/10.3390/nu12051470

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop